Komrokji, R S: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Outcome of Diffuse Large B-Cell Lymphoma in the United States Has Improved Over Time but Racial Disparities Remain: Review of SEER Data

Rami S. Komrokji, Najla H. Al Ali, M.S. Beg, Malek M. Safa, Dana Rollison, Mohamed Kharfan-Dabaja, Celeste Bello, Jennifer Cultrera, Lubomir Sokol, Javier Pinilla-Ibarz, Eduardo M. Sotomayor

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2011

Language:

english

File:

PDF, 419 KB

english, 2011

52

PSY72 VARIATION BY AGE IN HEALTH-RELATED QUALITY OF LIFE OF PATIENTS INITIATING TREATMENT FOR MYELODYSPLASTIC SYNDROMES

C. Pashos, D.L. Grinblatt, R.S. Komrokji, M.A. Sekeres, M. Narang, K.A. Sullivan, T.K. Street, Z.M. Khan

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 57 KB

english, 2011

53

PSY59 Variation in Health-Related Quality of Life Associated With Changes in Transfusion Status of Patients With Myelodysplastic Syndromes Across Six Months of Treatment With Azacitidine

C.L. Pashos, D.L. Grinblatt, M.A. Sekeres, R.S. Komrokji, M. Narang, A.S. Swern, T.K. Street, K.A. Sullivan, G. Harding, Z.M. Khan

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 60 KB

english, 2012

54

Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison

Phillips, Kristin M., Pinilla-Ibarz, Javier, Sotomayor, Eduardo, Lee, Morgan R., Jim, Heather S. L., Small, Brent J., Sokol, Lubomir, Lancet, Jeffrey, Tinsley, Sara, Sweet, Kendra, Komrokji, Rami, Jac

Journal:

Supportive Care in Cancer

Year:

2013

Language:

english

File:

PDF, 152 KB

english, 2013

55

Venous thromboembolism in patients with diffuse large B-cell lymphoma

Komrokji, Rami S., Uppal, Nikhil P., Khorana, Alok A., Lyman, Gary H., Kaplan, Karen L., Fisher, Richard I., Francis, Charles W.

Journal:

Leukemia and Lymphoma

Year:

2006

Language:

english

File:

PDF, 180 KB

english, 2006

56

Higher-risk myelodysplastic syndromes with del(5q): is sequential azacitidine–lenalidomide combination the way to go?

Zeidan, Amer M, Gore, Steven D, Komrokji, Rami S

Journal:

Expert Review of Hematology

Year:

2013

Language:

english

File:

PDF, 813 KB

english, 2013

57

Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion

Wei, S, Chen, X, McGraw, K, Zhang, L, Komrokji, R, Clark, J, Caceres, G, Billingsley, D, Sokol, L, Lancet, J, Fortenbery, N, Zhou, J, Eksioglu, E A, Sallman, D, Wang, H, Epling-Burnette, P K, Djeu, J,

Journal:

Year:

2013

Language:

english

File:

PDF, 2.27 MB

english, 2013

58

Myelodysplastic Syndromes Classification and Risk Stratification

Komrokji, Rami S., Zhang, Ling, Bennett, John M.

Journal:

Hematology/Oncology Clinics of North America

Year:

2010

Language:

english

File:

PDF, 1.94 MB

english, 2010

59

Outcome of azacitidine treatment in patients with therapy-related myeloid neoplasms with assessment of prognostic risk stratification models

Duong, Vu H., Lancet, Jeffrey E., Alrawi, Ezzideen, Al-Ali, Najla H., Perkins, Janelle, Field, Teresa, Epling-Burnette, Pearlie K., Zhang, Ling, List, Alan F., Komrokji, Rami S.

Journal:

Leukemia Research

Year:

2013

Language:

english

File:

PDF, 523 KB

english, 2013

60

There’s Risk, and Then There’s RISK: The Latest Clinical Prognostic Risk Stratification Models in Myelodysplastic Syndromes

Zeidan, Amer M., Komrokji, Rami S.

Journal:

Current Hematologic Malignancy Reports

Year:

2013

Language:

english

File:

PDF, 236 KB

english, 2013

61

Poor Outcome of Patients With Myelodysplastic Syndrome After Azacitidine Treatment Failure

Duong, Vu H., Lin, Karen, Reljic, Tea, Kumar, Ambuj, Al Ali, Najla H., Lancet, Jeffrey E., List, Alan F., Komrokji, Rami S.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2013

Language:

english

File:

PDF, 342 KB

english, 2013

62

Pretransplantation 5-Azacitidine in High-Risk Myelodysplastic Syndrome

Nishihori, Taiga, Perkins, Janelle, Mishra, Asmita, Komrokji, Rami, Kim, Jongphil, Kharfan-Dabaja, Mohamed A., Perez, Lia, Lancet, Jeffrey, Fernandez, Hugo, List, Alan, Anasetti, Claudio, Field, Teres

Journal:

Biology of Blood and Marrow Transplantation

Year:

2014

Language:

english

File:

PDF, 441 KB

english, 2014

63

Prognostic Factors and Risk Models in Myelodysplastic Syndromes

Komrokji, Rami S., Padron, Eric, Lancet, Jeffrey E., List, Alan F.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2013

Language:

english

File:

PDF, 151 KB

english, 2013

64

Deletion 5q MDS: Molecular and therapeutic implications

Komrokji, Rami S., Padron, Eric, Ebert, Benjamin L., List, Alan F.

Journal:

Best Practice & Research Clinical Haematology

Year:

2013

Language:

english

File:

PDF, 561 KB

english, 2013

65

P-229 GM-CSF-dependent pSTAT5 Sensitivity is a Feature of chronic myelomonocytic leukemia and a therapeutic target

Padron, E., Painter, J.S., Abdel-Wahab, O., Kunigal, S., Mailloux, A.W., McGraw, K.L., McDaniel, J., Bebbington, C., Baer, M., Yarranton, G., Lancet, J.E., Komrokji, R.S., List, A.F., Epling-Burnette,

Journal:

Leukemia Research

Year:

2013

Language:

english

File:

PDF, 65 KB

english, 2013

66

P-100 Validation of the Revised International Prognostic Scoring System (IPSS-R) and its therapeutic implications

Mishra, A., Corrales-Yepez, M., Al-Ali, N., Kharfan-Dabaja, M., Padron, E., Zhang, L., Epling-Burnette, P., Pinilla-Ibarz, J., Lancet, J.E., List, A.F., Komrokji, R.S.

Journal:

Leukemia Research

Year:

2013

Language:

english

File:

PDF, 744 KB

english, 2013

67

Prognostication in Myelodysplastic Syndromes: Beyond the International Prognostic Scoring System (IPSS)

Zeidan, Amer M., Smith, B. Douglas, Komrokji, Rami S., Gore, Steven D.

Journal:

The American Journal of Medicine

Year:

2013

Language:

english

File:

PDF, 119 KB

english, 2013

68

Ruxolitinib for Myelofibrosis–An Update of Its Clinical Effects

Kantarjian, Hagop M., Silver, Richard T., Komrokji, Rami S., Mesa, Ruben A., Tacke, Roland, Harrison, Claire N.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2013

Language:

english

File:

PDF, 353 KB

english, 2013

69

P-061 Optimization of telomerase reverse transcriptase as a molecular diagnostic in MDS

Fulp, W.F., Chen, D.T., Yang, L., Mailloux, A., Rollison, D.E., Wei, S., Liu, J.H., Komrokji, R., List, A.F., Epling-Burnette, P.K.

Journal:

Leukemia Research

Year:

2013

Language:

english

File:

PDF, 86 KB

english, 2013

70

Lenalidomide for Treatment of Myelodysplastic Syndromes: Current Status and Future Directions

Komrokji, Rami S., List, Alan F.

Journal:

Hematology/Oncology Clinics of North America

Year:

2010

Language:

english

File:

PDF, 439 KB

english, 2010

71

What Is “WHO“? Myelodysplastic Syndromes Classification

Komrokji, Rami S., Bennett, John M.

Journal:

Clinical Leukemia

Year:

2008

Language:

english

File:

PDF, 125 KB

english, 2008

72

P-130 Reticulin fibrosis in disease progression and overall survival of chronic myelomonocytic leukemia: An independent prognostic factor?

Peker, D., Liu, J., Padron, E., Lancet, J., List, A., Komrokji, R., Zhang, L.

Journal:

Leukemia Research

Year:

2013

Language:

english

File:

PDF, 251 KB

english, 2013

73

Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine

Adès, Lionel, Sekeres, Mikkael A., Wolfromm, Alice, Teichman, Melissa L., Tiu, Ramon V., Itzykson, Raphael, Maciejewski, Jaroslaw P., Dreyfus, Francois, List, Alan F., Fenaux, Pierre, Komrokji, Rami S

Journal:

Leukemia Research

Year:

2013

Language:

english

File:

PDF, 294 KB

english, 2013

74

Cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) compared to standard induction in acute myeloid leukemia from myelodysplastic syndrome after azanucleoside failure

Jaglal, Michael V., Duong, Vu H., Bello, Celeste M., Al Ali, Najla H., Padron, Eric, Fernandez, Hugo F., List, Alan F., Lancet, Jeffrey E., Komrokji, Rami S.

Journal:

Leukemia Research

Year:

2014

Language:

english

File:

PDF, 546 KB

english, 2014

75

A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediate-1-risk myelodysplastic syndrome

Garcia-Manero, Guillermo, Gartenberg, Gary, Steensma, David P., Schipperus, Martin R., Breems, Dimitri A., de Paz, Raquel, Valcárcel, David, Kranenburg, Britte, Reddy, Manjula, Komrokji, Rami S.

Journal:

American Journal of Hematology

Year:

2014

Language:

english

File:

PDF, 1013 KB

english, 2014

76

Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes

Komrokji, Rami S., Padron, Eric, Yu, Daohai, Fulp, William J., Rodriguez, Yuraima, Tinsley, Sara, List, Alan F., Lancet, Jeffrey E.

Journal:

American Journal of Hematology

Year:

2014

Language:

english

File:

PDF, 734 KB

english, 2014

77

Phase II pilot study of oral dasatinib in patients with higher-risk myelodysplastic syndrome (MDS) who failed conventional therapy

Duong, Vu H., Jaglal, Michael V., Zhang, Ling, Kale, Vishakha, Lancet, Jeffrey E., Komrokji, Rami S., List, Alan F.

Journal:

Leukemia Research

Year:

2013

Language:

english

File:

PDF, 239 KB

english, 2013

78

Update on the pharmacotherapy for myelodysplastic syndromes

Duong, Vu H, Komrokji, Rami S, List, Alan F

Journal:

Expert Opinion on Pharmacotherapy

Year:

2014

Language:

english

File:

PDF, 345 KB

english, 2014

79

Increased genomic instability may contribute to the development of kinase domain mutations in chronic myeloid leukemia

Sweet, Kendra, Al Ali, Najla H., Dalia, Samir M., Komrokji, Rami S., Crescentini, Robert M., Tinsley, Sara, Lancet, Jeffrey E., Papenhausen, Peter R., Zhang, Ling, Pinilla-Ibarz, Javier

Journal:

International Journal of Hematology

Year:

2014

Language:

english

File:

PDF, 330 KB

english, 2014

80

Multikinase inhibitors for treating high-risk myelodysplastic syndromes: can this be brought into clinical practice?

Duong, Vu H, Padron, Eric, List, Alan F, Komrokji, Rami S

Journal:

Expert Review of Hematology

Year:

2013

Language:

english

File:

PDF, 373 KB

english, 2013

81

Assessing efficacy in myelofibrosis treatment: a focus on JAK inhibition

Komrokji, Rami, Verstovsek, Srdan

Journal:

Expert Review of Hematology

Year:

2012

Language:

english

File:

PDF, 1.38 MB

english, 2012

82

A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study

Foss, Francine M., Sjak-Shie, Nelida, Goy, Andre, Jacobsen, Eric, Advani, Ranjana, Smith, Mitchell R., Komrokji, Rami, Pendergrass, Kelly, Bolejack, Vanessa

Journal:

Leukemia and Lymphoma

Year:

2013

Language:

english

File:

PDF, 259 KB

english, 2013

83

Patients with myelodysplastic syndromes treated with azacitidine in clinical practice: the AVIDA ® registry

Grinblatt, David L., Sekeres, Mikkael A., Komrokji, Rami S., Swern, Arlene S., Sullivan, Kristen A., Narang, Mohit

Journal:

Leukemia and Lymphoma

Year:

2015

Language:

english

File:

PDF, 1.96 MB

english, 2015

84

Gemtuzumab ozogamicin for treatment of newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis

Kharfan-Dabaja, Mohamed A., Hamadani, Mehdi, Reljic, Tea, Pyngolil, Rachel, Komrokji, Rami S., Lancet, Jeffrey E., Fernandez, Hugo F., Djulbegovic, Benjamin, Kumar, Ambuj

Journal:

British Journal of Haematology

Year:

2013

Language:

english

File:

PDF, 613 KB

english, 2013

85

Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer

Jazieh, A. R., Komrokji, R., Gupta, A., Patil, S., Flora, D., Knapp, M., Issa, M., Abdel Karim, N.

Journal:

Cancer Investigation

Year:

2009

Language:

english

File:

PDF, 159 KB

english, 2009

86

Acquisition of Signaling and ETV6 Mutations is Associated With Transformation to CMML

Padron, Eric, Teer, Jamie, Yoder, Sean, Kunigal, Sateesh, Painter, Jeff, Komrokji, Rami, Lancet, Jeff, Sotomayor, Eduardo, Epling-Burnette, Pearlie K., List, Alan F.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2014

Language:

english

File:

PDF, 80 KB

english, 2014

87

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

Patnaik, M M, Wassie, E A, Padron, E, Onida, F, Itzykson, R, Lasho, T L, Kosmider, O, Finke, C M, Hanson, C A, Ketterling, R P, Komrokji, R, Tefferi, A, Solary, E

Journal:

Blood Cancer Journal

Year:

2015

Language:

english

File:

PDF, 519 KB

english, 2015

88

Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency

Yang, L, Mailloux, A, Rollison, D E, Painter, J S, Maciejewski, J, Paquette, R L, Loughran, T P, McGraw, K, Makishima, H, Radhakrishnan, R, Wei, S, Ren, X, Komrokji, R, List, A F, Epling-Burnette, P K

Journal:

Year:

2013

Language:

english

File:

PDF, 2.10 MB

english, 2013

89

The role of pacritinib in the management of myelofibrosis

Duong, Vu H, Komrokji, Rami S

Journal:

Expert Review of Hematology

Year:

2014

Language:

english

File:

PDF, 299 KB

english, 2014

90

Current state of prognostication and risk stratification in myelodysplastic syndromes

Zeidan, Amer M., Gore, Steven D., Padron, Eric, Komrokji, Rami S.

Journal:

Current Opinion in Hematology

Year:

2015

Language:

english

File:

PDF, 290 KB

english, 2015

91

WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides

Brayer, Jason, Lancet, Jeffrey E., Powers, John, List, Alan, Balducci, Lodovico, Komrokji, Rami, Pinilla-Ibarz, Javier

Journal:

American Journal of Hematology

Year:

2015

Language:

english

File:

PDF, 922 KB

english, 2015

92

57 A PHASE 2 MULTICENTER STUDY OF CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) WHO FAIL TO ACHIEVE RESPONSE WITH INJECTABLE AZACITIDINE OR DECITABINE

Garcia-Manero, G., Silverman, L.R., Komrokji, R.S., Mufti, G.J., Seymour, J.F., Tsai, K., Reiser, D., Skikne, B.S., Beach, C.L., Fenaux, P.

Journal:

Leukemia Research

Year:

2015

Language:

english

File:

PDF, 152 KB

english, 2015

93

84 NOVEL MUTATIONS OF ENHANCER OF ZESTE HOMOLOG 2 (EZH2) MIGHT BE ASSOCIATED WITH ADVANCE DISEASE IN MYELODYSPLASIA RELATED MYELOID NEOPLASM - ONE CENTER STUDY

Zhou, J., Padron, E., Nguyen, J., Lancet, J., Komrokji, R., Bennett, J., Moscinski, L., List, A., Zhang, L.

Journal:

Leukemia Research

Year:

2015

Language:

english

File:

PDF, 106 KB

english, 2015

94

249 CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY

Steensma, D., Abedi, M., Bejar, R., Cogle, C., Foucar, K., Garcia-Manero, G., George, T., Grinblatt, D., Komrokji, R., Maciejewski, J., Pollyea, D., Roboz, G., Savona, M., Scott, B., Sekeres, M., Thom

Journal:

Leukemia Research

Year:

2015

Language:

english

File:

PDF, 106 KB

english, 2015

95

32 ACTIVATION OF REDOX-SENSITIVE INFLAMMASOMES UNDERLIES THE BIOLOGICAL PHENOTYPE OF MYELODYSPLASTIC SYNDROMES

Basiorka, A., Mcgraw, K., Eksioglu, E., Chen, X., Johnson, J., Padron, E., Komrokji, R., Sokol, L., Coll, R., O'Neill, L., Cooper, M., Robertson, A., Wei, S., List, A.

Journal:

Leukemia Research

Year:

2015

Language:

english

File:

PDF, 62 KB

english, 2015

96

286 THE NOVEL FC-ENGINEERED CD33 ANTIBODY BI 836858 IMPROVES HEMATOPOIESIS BY PROTECTING HSC/HPC FROM ROS-MEDIATED DNA DAMAGE IN MDS

Eksioglu, E.A., Chen, X., Heider, K.H., Rueter, B., Burnette, A., Wei, M., McGraw, K., Liu, J., Basiorka, A., Patel, P., Lancet, J., Komrokji, R., List, A., Wei, S.

Journal:

Leukemia Research

Year:

2015

Language:

english

File:

PDF, 72 KB

english, 2015

97

14 A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) OR NON-PROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ANEMIA REQUIRING TRANSFUSION

Komrokji, R., Garcia-Manero, G., Ades, L., Laadem, A., Vo, B., Prebet, T., Stamatoullas, A., Boyd, T., Delaunay, J., Steensma, D.P., Sekeres, M.A., Beyne-Rauzy, O., Zou, J., Attie, K.M., Sherman, M.L.

Journal:

Leukemia Research

Year:

2015

Language:

english

File:

PDF, 92 KB

english, 2015

98

Beyond hypomethylating agents failure in patients with myelodysplastic syndromes

Zeidan, Amer M., Kharfan-Dabaja, Mohamed A., Komrokji, Rami S.

Journal:

Current Opinion in Hematology

Year:

2014

Language:

english

File:

PDF, 265 KB

english, 2014

99

Phase I clinical trial of oral rigosertib in patients with myelodysplastic syndromes

Komrokji, Rami S., Raza, Azra, Lancet, Jeffrey E., Ren, Chen, Taft, David, Maniar, Manoj, Wilhelm, Francois, List, Alan F.

Journal:

British Journal of Haematology

Year:

2013

Language:

english

File:

PDF, 146 KB

english, 2013

100

Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion

Duong, V. H., Komrokji, R. S., List, A. F.

Journal:

Therapeutic Advances in Hematology

Year:

2012

Language:

english

File:

PDF, 615 KB

english, 2012